Drug (Compound) | Amantadine | Conotoxin GV | Tenocyclidine | Cycloleucine |
---|---|---|---|---|
Remarks for validation | Bioactivity/Medication: Amantadine can be used as an anti-parkinsonian agent, to treat extrapyramidal reactions, and for postherpetic neuralgia. | Enhanced Network: Conotoxin GV is known to act on N-methyl D-aspartate acid receptor (NMDA receptor) | Sharing target protein: Tenocyclidine share four target proteins with memantine: Alpha-7 nicotinic cholinergic receptor subunit, Glutamate receptor ionotropic, NMDA 2A / 2B / 3A | Sharing target protein: Cycloeucine share one target protein with memantine: Glutamate receptor ionotropic, NMD1; PMID10051153, 7,773,540 |